Results 141 to 150 of about 17,756 (247)

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation. [PDF]

Antibodies (Basel)
Bruzzese A, Martino EA, Caserta S, Alvaro ME, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F, Morabito F, Vigna E, Gentile M.   +11 more
europepmc   +1 more source

Pediatric AML CAR T cell therapy. [PDF]

Mol Ther Oncol
Bhagwat AS, Naik S.
europepmc   +1 more source

Anti-CD123 Monoclonal Antibody CSL360 [PDF]

, 2020
openaire   +1 more source

A PBD dimer-containing antibody-drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease. [PDF]

Blood Adv
Naji NS, Ahmedna T, Zeng X, An Y, Hemani Y, Perkins B, Thompson Z, Nichakawade TD, Wang Y, Lee BS, Watson E, Chatzilygeroudi T, Luo L, Paun B, Klausner M, Supeanu T, Gojo I, Ghiaur G, DeZern AE, Levis MJ, Resar L, Jones RJ, Peske JD, Karanika S, Paul S, Karantanos T.   +25 more
europepmc   +1 more source

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia. [PDF]

Front Immunol
Wang Y, Yu T, Wang M, Yu L.
europepmc   +1 more source

LSC-like Phenotypes Aid in the Prognosis of Adult and Elderly Acute Myeloid Leukemia Patients at a Resource-Limited Health Center. [PDF]

Cancers (Basel)
Dias CK, Alves HC, Rostirola RB, Gonçalves Meirelles Fernandes MF, Sant'Ana AN, Alegretti AP, Farias MG, da Silva PP, Astigarraga CC, Daudt LE, Michalowski MB, Paz AA, Figueiró F.   +12 more
europepmc   +1 more source

Novel treatment strategies in acute myeloid leukemia. [PDF]

Blood Res
Simkhada S, Joshi U, Dhakal P.
europepmc   +1 more source

Application and challenges of chimeric antigen receptor T cell therapy in the treatment of acute myeloid leukemia (Review). [PDF]

Oncol Lett
Zhang J, Wang F, Sui D, Huang Z, Chen Y.
europepmc   +1 more source

IL-3 receptor-α (CD123) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia. [PDF]

Front Immunol
Rasouli M, Dalem M, Raaijmakers MHGP, Katsikis PD, Erkeland SJ.   +4 more
europepmc   +1 more source